Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.04 USD | +1.14% | +15.08% | +36.13% |
07-15 | Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating | MT |
07-01 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell Small Cap Comp Value Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.13% | 1.13B | |
0.00% | 8.92B | |
-20.00% | 2.62B | |
-22.21% | 2.37B | |
-24.79% | 1.9B | |
-17.39% | 982M | |
-18.86% | 928M | |
+0.83% | 759M | |
-32.38% | 629M | |
-39.63% | 536M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Transcript : Core Laboratories N.V., Q4 2020 Earnings Call, Jan 28, 2021